These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37470181)

  • 21. Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model.
    Mas-Stachurska A; Siegert AM; Batlle M; Gorbenko Del Blanco D; Meirelles T; Rubies C; Bonorino F; Serra-Peinado C; Bijnens B; Baudin J; Sitges M; Mont L; Guasch E; Egea G
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28947563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome.
    Franken R; Teixido-Tura G; Brion M; Forteza A; Rodriguez-Palomares J; Gutierrez L; Garcia Dorado D; Pals G; Mulder BJ; Evangelista A
    Heart; 2017 Nov; 103(22):1795-1799. PubMed ID: 28468757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
    Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
    J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
    Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome.
    Ng B; Xie C; Su L; Kuthubudeen FF; Kwek XY; Yeong D; Pua CJ; Cook SA; Lim WW
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):739-754. PubMed ID: 36924234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome.
    Bellini C; Korneva A; Zilberberg L; Ramirez F; Rifkin DB; Humphrey JD
    J Biomech; 2016 Aug; 49(12):2383-2389. PubMed ID: 26755343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive detection of abnormal aortic architecture in Marfan syndrome with high-frequency ultrasonic tissue characterization.
    Recchia D; Sharkey AM; Bosner MS; Kouchoukos NT; Wickline SA
    Circulation; 1995 Feb; 91(4):1036-43. PubMed ID: 7850939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex, pregnancy and aortic disease in Marfan syndrome.
    Renard M; Muiño-Mosquera L; Manalo EC; Tufa S; Carlson EJ; Keene DR; De Backer J; Sakai LY
    PLoS One; 2017; 12(7):e0181166. PubMed ID: 28708846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of lysyl oxidase in the pathogenesis of arterial stiffness in chronic kidney disease.
    Sharma RK; Kamble SH; Krishnan S; Gomes J; To B; Li S; Liu IC; Gumz ML; Mohandas R
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F364-F373. PubMed ID: 36825626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice.
    Mariko B; Pezet M; Escoubet B; Bouillot S; Andrieu JP; Starcher B; Quaglino D; Jacob MP; Huber P; Ramirez F; Faury G
    J Pathol; 2011 May; 224(1):33-44. PubMed ID: 21432852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
    Seppelt PC; Schwill S; Weymann A; Arif R; Weber A; Zaradzki M; Richter K; Ensminger S; Robinson PN; Wagner AH; Karck M; Kallenbach K
    PLoS One; 2016; 11(2):e0148012. PubMed ID: 26840980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular pathology of Marfan syndrome].
    Tamura K
    Kyobu Geka; 2002 Jul; 55(8 Suppl):616-22. PubMed ID: 12174645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic dilatation in Marfan syndrome: role of arterial stiffness and fibrillin-1 variants.
    Salvi P; Grillo A; Marelli S; Gao L; Salvi L; Viecca M; Di Blasio AM; Carretta R; Pini A; Parati G
    J Hypertens; 2018 Jan; 36(1):77-84. PubMed ID: 29210860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical assessment of elastin integrity in fibrillin-1-deficient carotid arteries: implications for Marfan syndrome.
    Ferruzzi J; Collins MJ; Yeh AT; Humphrey JD
    Cardiovasc Res; 2011 Nov; 92(2):287-95. PubMed ID: 21730037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.
    Okamura H; Pisani LJ; Dalal AR; Emrich F; Dake BA; Arakawa M; Onthank DC; Cesati RR; Robinson SP; Milanesi M; Kotek G; Smit H; Connolly AJ; Adachi H; McConnell MV; Fischbein MP
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):690-6. PubMed ID: 24814820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.